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 Revista Brasileira de Farmacognosia-
Brazilian Journal of Pharmacognosy, is back in the 
group of international journals with Impact Factor, 
in the list’s disclosure last June by Thomson Reuters. 
Although other Brazilian journals have also gone 
through the same problem that removed us from the 
list for two years, none of them has experienced the 
same negative consequences as RBFAR has suffered. 
Thus, this is a time to celebrate, not only because of 
the value we have attained but also because of the 
positive repercussions that result from our recovering 
our credibility within the scientifi c community. 
Of 99 Brazilian journals indexed in the Journal 
Citation Reports (JCR, 2012), we are in 32nd place. 
 
 
 First of all, in regard to the Impact Factor (IF) 
published in JCR 2010, I remind colleagues that we 
wrote an editorial stating that we did not accept that 
published value and we did consider only an IF of 
0.327, without counting self-citations. We also said at 
that time that from 0.327 we should grow. Today, our 
IF without self-citations is 0.509, and in spite of all 
the diffi culties we have had, we are growing, and our 
self-citations have been reduced from 86% to 23%. 
 Secondly, we understand that, from now on, we 
have to consider our IF in its full amount, including self-
citations. This is because, as a result of the experience 
of analyzing our self-citations these last few years, we 
can say that: i) they are not addressed, and ii) they 
represent most of the work with Brazilian medicinal 
plants, done for Brazilian scientists who publish these 
results in a Brazilian scientifi c journal. For example, 
who in the world works with barbatimão or other native 
plant species? So, we achieved in the JCR 2012 an IF 
of 0.676, and from this value we must continue to grow.
 Finally, the way ahead is well described in 
our editorial published in issue 2 this year, when we 
wrote that growth for Brazilian journals will come 
with professionalization, and this will be our goal 
going forward. We have new plans, new directions, 
new working group and new perspectives - but always 
aiming to give greater visibility to the articles we 
publish based on our research on natural products, 
especially in Brazil, as well as providing opportunities 
for our students and for our post-graduate programs.
 To start this new stage, we are pleased 
to announce in this editorial our partnership with 
Elsevier. With this, we are beginning a new era in 
the RBFAR, where our articles will be published 
by an internationally recognized publisher and will 
have open access availability at ScienceDirect portal.
 By fi nishing that phase, and we have to thank 
the authors who believed in our journal by submitting 
articles even without an IF. The merit of what we 
have achieved is dedicated to the quality of what was 
published. However, to achieve and to improve the 
quality of papers, we must recognize the hard work 
and dedication of a vibrant community of scientists 
who have committed many volunteer hours to us over 
the past years to guide our choices of what to publish; 
a special thanks to our peer reviewers and editors. A 
list of those who agreed and have completed a review 
of manuscripts since June 2009 is published below. 
They worked tirelessly without pay, and there are 
no words to express our immense appreciation and 
gratitude. l have also to thank my students (Claudia 
Seidl, Luma Wosch, Joélia Carvalho, Juliana Lozich, 
and Camila Ottoboni), who helped me along these 
years by checking bibliographies and managing and 
editing all published articles in RBFAR thus far. 
Their dedication was exceptional and my gratitude is 
diffi cult to express.
Along with this spirit of celebration, some 
considerations are necessary in thinking about the 
future of the journal. 
